Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 801 results for "hodgkin"

Police and students rally to support 13 year old fighting cancer

4:24 PM CT In January, 13 year old Ethan Scott was diagnosed with an aggressive form of non Hodgkins Lymphoma and on Tuesday, classmates and even some members of the Winnipeg Police Service shaved their heads, in a packed gymnasium, in support of ... CBC, 18 hours ago
Forum Post: RE: Non Hodgkin's lymphoma Macmillan Cancer Support, 20 hours ago
[x]  

80 images for hodgkin

Cancer Therapy Advisor, 6 days ago
Targeted Oncology, 1 week ago
Nasdaq, 1 week ago
Pharmafile, 1 week ago
Stuff.co.nz, 1 week ago
NewsGrio, 2 weeks ago
Breaking News.ie, 1 week ago
Monthly Prescribing Reference, 1 week ago
Macmillan Cancer Support, 1 week ago
Archaeology Magazine, 1 week ago
NBC Sports

Pitt RB James Conner says he is cancer-free

Pittsburgh running back James Conner says he is cancer-free, less than six months after being diagnosed with Hodgkin lymphoma. Conner posted on his Twitter account Monday: "God is AMAZING. Just got the call that my body is clean of cancer!!!" Been ...
 USA Today1 day ago Now cancer free, Pitt's Conner thankful for wealth of support  Miami Herald20 hours ago Pitt running back James Conner receives cancer-free diagnosis  Examiner.com1 day ago Pitt RB Conner announces hes free of cancer  ESPN.co.uk1 day ago
[x]  
Cancer Therapy Advisor

Physician Views: How much enthusiasm is there for using Opdivo in cHL and other blood cancers?

Opdivo (nivolumab) from Bristol-Myers Squibb was just granted accelerated approved by the FDA to treat classical Hodgkin's lymphoma (cHL), marking the first label expansion for a mAb against PD-(L)1 into a haematological malignancy. In the ...
 FirstWord Pharma2 days ago FDA Approves Nivolumab for Relapsed Classical Hodgkin Lymphoma  OncoTherapy Network4 days ago FDA Approves Opdivo (nivolumab) to Treat Advanced Classical Hodgkin Lymphoma  LymphomaNewsToday.com6 days ago FDA OKs new use of Bristol-Myers' Opdivo; first PD-1 inhibitor approved for blood cancer  Seeking Alpha1 week ago
[x]  
The Press NZ

'Toothache' turned out to be tumour

Huntar Sammons was diagnosed with Burkitt non-Hodgkin lymphoma, a fast-growing form of cancer. Doctors originally thought he had a toothache. A boywho passed out in ahospitalwaitingroom fromunbearable pain was sent home by doctors, who told his ...
 The Press NZ1 week ago Childhood Cancer: Luke Burkitt's Lymphoma Story  LymphomaNewsToday.com6 days ago 'Toothache' actually a tumour  Stuff.co.nz1 week ago Wellington mother says her son's brain tumors were shrugged off as toothache  Dominion Post1 week ago
Nasdaq

Bristol-Myers' Opdivo Wins FDA Nod for Additional Indication

Bristol-Myers Squibb Company BMY announced that the FDA has approved Opdivo for the treatment of classical Hodgkin lymphoma (cHL) in patients who have relapsed or progressed after autologous hematopoietic stem cell transplantation (auto-HSCT) and ...
 Yahoo! Finance1 week ago
[x]  

Surveillance Imaging in Patients in Remission From Hodgkin and Diffuse Large B-Cell Lymphoma

Also Meets CME requirements for: Browse CME for all U.S. States The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA ...
 Journal of the American Medical Association1 week ago

Minimal Treatment of Low-Risk, Pediatric Lymphocyte-Predominant Hodgkin Lymphoma: A Report From the Children's Oncology Group [Pediatric Oncology]

Abstract Purpose Children's Oncology Group study AHOD03P1 was designed to determine whether excellent outcomes can be maintained for patients with low-risk, pediatric lymphocyte-predominant Hodgkin lymphoma (LPHL) with a strategy of resection ...
 Journal of Clinical Oncology1 week ago
Mashable

Two-time cancer survivor gets his wish and meets Luke Skywalker

After exhausting every option, Jamie Harkin was finally able to meet his hero: Luke Skywalker. Harkin has survived Hodgkins Lymphoma cancer twice, and made it one of his missions to meet some of his Star Wars heroes. Harkin has also set up ...
 Mashable1 week ago

Global Hodgkin Lymphoma Market - Competitive Landscape Highlights 2016 - Research and Markets

Research and Markets has announced the addition of the "Global Hodgkin Lymphoma Market and Competitive Landscape Highlights - 2016" report to their offering. Research and Markets has announced the addition of the report to their offering. The ...
 BioSpace5 days ago
[x]  

Sylvester researchers test new KTE-C19 therapy for patients with aggressive non-Hodgkin's lymphoma

Researchers at Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine are testing a novel cellular immunotherapy approach to treating patients with diffuse large B-cell lymphoma who have failed standard therapy.
 News-Medical.Net3 minutes ago Novel immunotherapy trial for lymphoma offers hope to patients  HealthMediciNet.com1 day ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
Related Queries - hodgkin
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less